- The Evolution of Bowel Preparation and New Developments
-
Park JB, Lee YK, Yang CH
- KMID: 2155324
- Korean J Gastroenterol.
- 2014 May;63(5):268-275.
- doi: 10.4166/kjg.2014.63.5.268
Bowel preparation is essential for successful colonoscopy examination, and the most important factor is the bowel preparation agent used. However, selection of a bowel preparation agent invariably involves compromise. Originally,... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Chronic Hepatitis C: Shorter Treatment Duration for Genotype 2 or 3 Infection
-
Jeong SH
- KMID: 760731
- Korean J Hepatol.
- 2007 Sep;13(3):301-303.
- doi: 10.3350/kjhep.2007.13.3.301
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Does Polyethylene Glycol (PEG) Plus Ascorbic Acid Induce More Mucosal Injuries than Split-Dose 4-L PEG during Bowel Preparation?
-
Kim MS, Park J, Park JH, Kim HJ, Jang HJ, Joo HR, Kim JY, Choi JH, Heo NY, Park SH, Kim TO, Yang SY
- KMID: 2363968
- Gut Liver.
- 2016 Mar;10(2):237-243.
- doi: 10.5009/gnl14439
BACKGROUND/AIMS: The aims of this study were to compare the bowel-cleansing efficacy, patient affinity for the preparation solution, and mucosal injury between a split dose of poly-ethylene glycol (SD-PEG) and... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Chronic Hepatitis C
-
Chang YJ, Byun KS
- KMID: 772701
- Korean J Gastroenterol.
- 2004 Dec;44(6):301-307.
Chronic infection with HCV represents second most common cause of end-stage liver diseases and hepatocellular carcinoma in Korea. The introduction of new agents and regimens for the treatment of chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Clear Liquid Diet Is Not Mandatory for Polyethylene Glycol-Based Bowel Preparation for Afternoon Colonoscopy in Healthy Outpatients
-
Jung YS, Seok HS, Park DI, Song CS, Kim SE, Lee SH, Eun CS, Han DS, Kim YS, Lee CK
- KMID: 1712328
- Gut Liver.
- 2013 Nov;7(6):681-687.
BACKGROUND/AIMS: A dietary regimen consisting of a clear liquid diet (CLD) for at least 24 hours is recommended for colonoscopy preparation. However, this requirement results in problems in patient compliance... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Toxicity by Pegylated Interferon alpha-2a in a Patient with Chronic Hepatitis C
-
Son BK, Sohn JH, Kim TY, Park YK, Jeon YC, Han DS
- KMID: 760711
- Korean J Hepatol.
- 2007 Mar;13(1):103-107.
The combination therapy with pegylated interferon alpha and ribavirin has increasingly prescribed for chronic hepatitis C. Although many side effects of interferon such as flu-like symptoms, gastrointestinal and neuropsychiatric symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C
-
Kim KT, Han SY, Kim JH, Yoon HA, Baek YH, Kim MJ, Lee SW, Jang JS, Lee JH, Roh MH
- KMID: 1073328
- Korean J Hepatol.
- 2008 Mar;14(1):36-45.
- doi: 10.3350/kjhep.2008.14.1.36
BACKGROUND/AIMS: The purpose of this study is to elucidate the efficacy and safety of combined peginterferon and ribavirin therapy in Korean patients with chronic HCV infection. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Culture and Polymerase Chain Reaction of Helicobacter pylori from Rectal and Terminal Ileal Fluid after Polyethylene Glycol (Colyte(R)) Ingestion in Healthy Adults with Positive Urea Breath Test
-
Kim DH, Jung HM, Hwang YJ, Ahn YS, Mun JS, Myoung BH, Park H, Jeong EJ, Im YM, Oh HM, Jeong HY, Park C, Kim HR, Cho EH, Kim HD, Jung YD
- KMID: 1775875
- Korean J Gastroenterol.
- 2010 Jul;56(1):27-32.
- doi: 10.4166/kjg.2010.56.1.27
BACKGROUND/AIMS: Helicobacter pylori (H. pylori) transmission route is not yet clearly understood. Isolating H. pylori from stool, saliva, and vomitus is very difficult. However, H. pylori could be cultured from... -
- CITED
-
- Close
- SHARE
-
- Close
- Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo
-
Han SY, Lee YJ, Jung HI, Lee SW, Lim SJ, Hong SH, Jeong JS
- KMID: 1094122
- Exp Mol Med.
- 2008 Aug;40(4):427-434.
- doi: 10.3858/emm.2008.40.4.427
Use of adenoviruses as vehicle for gene therapy requires that target cells express appropriate receptors such as coxsakievirus and adenovirus receptor (CAR). We show here that CAR-deficiency in cancer cells,... -
- CITED
-
- Close
- SHARE
-
- Close
